Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments

Pharmaceutical Research, Mar 2018

Willem Johan van den Brink, Semra Palic, Isabelle Kohler, Elizabeth Cunera Maria de Lange

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs11095-018-2388-3.pdf

Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments

Pharm Res Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments Willem Johan van den Brink 0 Semra Palic 0 Isabelle Kohler 0 Elizabeth Cunera Maria de Lange 0 Wong YC 0 G├╝lave B 0 van der Graaf PH 0 . Available from: http://link.springer.com/ 0 Elizabeth Cunera Maria de Lange 0 0 Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University , Einsteinweg 55, 2333 CC Leiden , The Netherlands


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs11095-018-2388-3.pdf

Willem Johan van den Brink, Semra Palic, Isabelle Kohler, Elizabeth Cunera Maria de Lange. Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments, Pharmaceutical Research, 2018, 102, DOI: 10.1007/s11095-018-2388-3